Aran Biomedical

Spiddal, Ireland Founded: 2002 • Age: 24 yrs Acquired By Integer
Biomaterials for implantable medical devices are developed for surgical applications.

About Aran Biomedical

Aran Biomedical is a company based in Spiddal (Ireland) founded in 2002 was acquired by Integer in April 2022. Aran Biomedical offers products and services including Medical Textiles, Implant Coating, Nitinol Braiding, and PTFE Implant Covering. Aran Biomedical operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.

  • Headquarter Spiddal, Ireland
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website aranbiomedical.com
  • Social LinkedIn YouTube
  • Acquired by Integer (Apr 2022)
  • Legal Name Aran Biomedical Teoranta
Key Metrics
  • Latest Funding Round
    $289.47K (USD), Grant

    Feb 2016

  • Investors
    Integer

    & 1 more

  • Acquired by
    Integer

    (Apr 2022)

Products & Services of Aran Biomedical

Aran Biomedical offers a comprehensive portfolio of products and services, including Medical Textiles, Implant Coating, Nitinol Braiding, and PTFE Implant Covering.

Medical Textiles
Implant Materials

Custom fabrics for implantable medical devices and applications.

Implant Coating
Surface Treatments

Coating services to enhance implant performance and durability.

Nitinol Braiding
Material Processing

Braiding technology for flexible and strong medical implants.

PTFE Implant Covering
Implant Components

Covering solutions for stents and other medical devices.

Apps and channels of Aran Biomedical

its YouTube channel Aran Biomedical has 75 subscribers and 13 videos.

Aran Biomedical
YouTube 75 subscribers 13 videos Science & Technology
Open channel

Videos from Aran Biomedical

The most watched videos on Aran Biomedical's YouTube channel, Aran Biomedical (75 subscribers). Click a video to play it here.

Aran Biomedical Corporate Video
5.8K views
Implant Development Solutions
4.2K views
Advanced Nitinol Braiding - Aran Biomedical
2.8K views
Aran Biomedical - High Precision Implant Coating Solutions
1.1K views

More on Aran Biomedical.

Funding Insights of Aran Biomedical

  • Total Rounds 1
  • Last Round Grant β€” $289,466
  • First Round $289,466

    (Feb 2016)

  • Investors Count 1

All 1 funding rounds of Aran Biomedical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Feb 2016$289,466Grant––
Valuation history

2 investors in total: 2 institutional.

Investors in Aran Biomedical

Aran Biomedical has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Integer and European Union.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
–europa.eu-
Medical device components are developed and manufactured for healthcare markets.
1970integer.netFrisco, United States
Premium access

Investor details for Aran Biomedical

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Aran Biomedical

3 people are tracked at Aran Biomedical (1 in leadership, 2 in team).

NameRoleGroup
Todd Blair
Vice President of Sales and Business Development, USLeadership
Michael Conroy
Machine OperatorTeam
Dean King
Business Unit Manager, Medical TextilesTeam
Premium access

Complete people profiles for Aran Biomedical

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Aran Biomedical

3 dated milestones of Aran Biomedical across 20 years, from founding to its latest funding, stage changes and deals.

  1. Founded Aran Biomedical is founded.
  2. Funding First funding round of $289K.
  3. Exit Acquired by Integer.

Competitors of Aran Biomedical

Aran Biomedical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
gsk.com1715Brentford, United Kingdom–90,913
Developer of pharmaceuticals and vaccines for various therapeutic areas
aviditybiosciences.com2012San Diego, United States$142.54M253
Antibody-siRNA complexes are developed for cancer treatment.
sutrobio.com2003United States$171.85M235
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
antheia.bio2013Palo Alto, United States$152.37M50
Yeast cells are genetically engineered to produce medicinal products.
vividion.com2016Oceanside, United States$270.5M123
Developing novel drugs based on a proteome-wide ligand and target discovery platform
synthego.com2012Redwood, United States$459.75M–
CRISPR-engineered cell and gene therapies are developed for research applications.
univercells.com2013Charleroi, Belgium$150.64M87
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
korrobio.com2018Cambridge, United States$4M77
RNA-editing technologies are provided for precision medicine applications.
savarapharma.com2008Austin, United States$67.82M37
Therapeutics for rare respiratory diseases are developed by Savara Pharma.
lifeminetx.com2016Cambridge, United States$300.07M85
Developer of novel drugs from fungi via genome mining and recombinant overexpression
Premium access

Detailed competitors of Aran Biomedical

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Aran Biomedical

Websites that share an audience with Aran Biomedical (aranbiomedical.com).

Similar websites

Websites whose visitors overlap most with Aran Biomedical. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
surgicalmesh.com
surgicalmesh.com
100%
–#4,599,553–

Latest news on Aran Biomedical

Premium access

Complete news archive for Aran Biomedical

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Aran Biomedical

10 companies that operate in the same segment as Aran Biomedical (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M––
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B––
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.3 BUSD 301.49 M1,480
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M––
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M––
Biological reagents and antibodies are developed for life science research.
1998Cambridge, Cambridgeshire, United KingdomUSD 78.8 M––
Electron microscopy services and microanalysis instruments are provided.
1956Waltham, Massachusetts, United States–USD 44.56 B125,000
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
A platform for sharing and accessing academic research papers is provided.
2008San Francisco, California, United StatesUSD 58.4 M––
Developer of molecular diagnostic testing solutions
1996Sunnyvale, California, United StatesUSD 19.1 MUSD 54.88 M208
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Aran Biomedical

Aran Biomedical was founded in 2002 and raised its 1st funding round 14 years after it was founded.

Aran Biomedical is headquartered in Spiddal, Ireland. It is registered at Spiddal, County Galway, Ireland.

Aran Biomedical was founded in 2002 in Spiddal, Ireland, within the biomedical sector. Biomaterials are developed by the company, including medical textiles, coverings, and coatings for implants, as well as materials for absorbable devices. Operations center on applications in general surgery, cardiovascular procedures, and orthopedics. Solutions are provided to support the design and functionality of implantable medical devices across these medical fields.

Aran Biomedical's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.

Aran Biomedical offers Medical Textiles, Implant Coating, Nitinol Braiding, and PTFE Implant Covering.

Aran Biomedical has 2 investors. Key investors include Integer, and European Union.

Aran Biomedical operates through Aran Biomedical Teoranta.

Yes. Aran Biomedical was acquired by Integer in April 2022.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available